BerGenBio — Major Shareholding Notification 2023

May 25, 2023

ID	Item	Value
A / 13.9.1.1	Name of the issuer of the shares	BerGenBio ASA
B / 13.9.1.2	Date when the ownership interest reached, exceeded or fell below a threshold established in the Securities Trading Act section 4-3 subsection (1)	Date: 24-05-2023
C / 13.9.1.3	(1) Name of the entity subject to a disclosure obligation, and (2) the name of shareholders which have assigned voting rights	(1) Nordea Funds Ltd.
D / 13.9.1.4	Number of shares, rights or voting rights involved in transaction	2,000,332
E / 13.9.1.5	Number of voting rights, including the per centage of the share capital and voting rights held by entity following the transaction	Voting Rights: 3,171,681.00 % shares: 3.57733% % votes: 3.57733%
F / 13.9.1.6	Percentage of shares and votes in the company held by the party concerned in the form of rights to shares	N/A
G / 13.9.1.7	The circumstance that triggered the disclosure obligation, and whether this applied to the party concerned himself or to related parties as mentioned in the Securities Trading Act section 2-5	Share disposal
H / 13.9.1.8	The chain of controlled companies through which the shares or rights are owned	N/A
I / 13.9.1.9	Notifications applying to rights to shares as mentioned in the Securities Trading Act section 4-3 subsection (4)	N/A